WO2000067779A3 - Polymerized liposomes for the delivery of mammalian growth hormone - Google Patents

Polymerized liposomes for the delivery of mammalian growth hormone Download PDF

Info

Publication number
WO2000067779A3
WO2000067779A3 PCT/US2000/012902 US0012902W WO0067779A3 WO 2000067779 A3 WO2000067779 A3 WO 2000067779A3 US 0012902 W US0012902 W US 0012902W WO 0067779 A3 WO0067779 A3 WO 0067779A3
Authority
WO
WIPO (PCT)
Prior art keywords
delivery
growth hormone
mammalian growth
polymerized liposomes
present
Prior art date
Application number
PCT/US2000/012902
Other languages
French (fr)
Other versions
WO2000067779A2 (en
Inventor
Hansi J Dean
Kyle Bucher
Elijah Bolotin
Original Assignee
Endorex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorex Corp filed Critical Endorex Corp
Priority to AU50040/00A priority Critical patent/AU5004000A/en
Publication of WO2000067779A2 publication Critical patent/WO2000067779A2/en
Publication of WO2000067779A3 publication Critical patent/WO2000067779A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Abstract

The present invention encompasses polymerized liposomes systems for oral and/or mucosal delivery of protein drugs. In a preferred embodiment, the polymerized liposome is modified to contain mammalian growth hormone for the delivery of biologically active hormone after mucosal administration. The present invention further relates to the synthesis, preparation and use of the polymerized liposomes of the present invention as, or in, pharmaceutical compositions for oral delivery of bioactive molecules, in particular, mammalian growth hormone.
PCT/US2000/012902 1999-05-12 2000-05-11 Polymerized liposomes for the delivery of mammalian growth hormone WO2000067779A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU50040/00A AU5004000A (en) 1999-05-12 2000-05-11 Polymerized liposomes for the delivery of mammalian growth hormone

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13369699P 1999-05-12 1999-05-12
US60/133,696 1999-05-12

Publications (2)

Publication Number Publication Date
WO2000067779A2 WO2000067779A2 (en) 2000-11-16
WO2000067779A3 true WO2000067779A3 (en) 2001-01-18

Family

ID=22459889

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/012902 WO2000067779A2 (en) 1999-05-12 2000-05-11 Polymerized liposomes for the delivery of mammalian growth hormone

Country Status (2)

Country Link
AU (1) AU5004000A (en)
WO (1) WO2000067779A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2274011A4 (en) * 2008-04-17 2013-04-24 Banyan Biomarkers Inc An antibody bound synthetic vesicle containing active agent molecules

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366881A (en) * 1993-02-23 1994-11-22 The United States Of America As Represented By The Secretary Of The Navy Polymerizable lipids for preparing vesicles that controllably release an encapsulant
WO1995003035A1 (en) * 1993-07-23 1995-02-02 Massachusetts Institute Of Technology Polymerized liposomes with enhanced stability for oral delivery
WO1999033940A1 (en) * 1997-12-31 1999-07-08 Orasomal Technologies, Inc. Novel polymerizable fatty acids, phospholipids and polymerized liposomes therefrom

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366881A (en) * 1993-02-23 1994-11-22 The United States Of America As Represented By The Secretary Of The Navy Polymerizable lipids for preparing vesicles that controllably release an encapsulant
WO1995003035A1 (en) * 1993-07-23 1995-02-02 Massachusetts Institute Of Technology Polymerized liposomes with enhanced stability for oral delivery
WO1999033940A1 (en) * 1997-12-31 1999-07-08 Orasomal Technologies, Inc. Novel polymerizable fatty acids, phospholipids and polymerized liposomes therefrom

Also Published As

Publication number Publication date
WO2000067779A2 (en) 2000-11-16
AU5004000A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
CA2329005A1 (en) Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
AU6819294A (en) Oral drug delivery compositions and methods
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
WO2002015903A3 (en) Novel pharmaceutical composition for administering n-0923
WO2002051390A3 (en) Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
AU694229B2 (en) A pharmaceutical preparation comprising glucagon
AU4334700A (en) Pharmaceutical dosage form for pulsatile delivery of methylphenidate
TW366286B (en) Flavour-masked pharmaceutical compositions
HUP0104255A2 (en) An pharmaceutical composition suitable for inhalation
CA2203033A1 (en) Compounds and compositions for delivering active agents
AU1079701A (en) Oral transmucosal drug dosage using solid solution
AU1798101A (en) Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
ZA200600027B (en) Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
HUP0102337A2 (en) Process for preparation of compositions for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
IE894048L (en) New therapeutically active compound and a process for its¹preparation
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
DE69521688D1 (en) PHARMACEUTICAL Brewing Preparations Containing Biodegradable Microcapsules For Controlled Release Of Active Ingredients
DE60126433D1 (en) PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS
AU1307399A (en) Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
CA2141026A1 (en) Pharmaceutical Compositions for Transmucosal Delivery of Peptides
CA2287534A1 (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
EP1279406A4 (en) Transporters and drug delivery system by using the same
AU4363199A (en) Use of hmg proteins for the preparation of medicaments having cytotoxic activity
WO2002058589A3 (en) Agents and methods for promoting bone growth
CA2326348A1 (en) Liposomal bupivacaine compositions and methods of preparation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP